Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir K Gupta

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Pharmacology|October 2, 2007
Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairmentSamir K Gupta, Bhavna Kantesaria, Zaiqi Wang
AIDS (London, England)|January 6, 2025
The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysisSamir K Gupta, Allon N Friedman, Zeruesenay Desta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2022
A 58-Year-old Man With Multifocal Pulmonary NodulesMitchell McClean, Samir K Gupta, Ryan F Relich
European Journal of Clinical Pharmacology|December 17, 2010
Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis CSamir K Gupta, Karen Kolz, David L Cutler
AIDS Patient Care and Stds|April 8, 2011
Endothelial, inflammatory, coagulation, metabolic effects and safety of etravirine in HIV-uninfected volunteersSamir K Gupta, Deming Mi, Ziyue Liu, et al.
The Journal of Trauma|January 12, 2007
Splenic rupture after colonoscopy: case report and literature reviewSteven S Tsoraides, Samir K Gupta, Norman C Estes
AIDS (London, England)|May 12, 2016
Frequency of atazanavir-associated leukocyturia development and renal function declineLana Dbeibo, Sana Arif, Fei He, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adultsSamir K Gupta, Bhavna Kantesaria, Christopher Banfield, et al.
British Journal of Clinical Pharmacology|July 10, 2003
Single-dose pharmacokinetics and tolerability of pegylated interferon-alpha2b in young and elderly healthy subjectsSamir K Gupta, Paul Glue, Sheila Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2015
A randomized, controlled trial of the effect of rilpivirine versus efavirenz on cardiovascular risk in healthy volunteersSamir K Gupta, James E Slaven, Lisa M Kamendulis, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Pharmacology|October 2, 2007
Multiple-dose pharmacokinetics and safety of desloratadine in subjects with moderate hepatic impairmentSamir K Gupta, Bhavna Kantesaria, Zaiqi Wang
AIDS (London, England)|January 6, 2025
The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysisSamir K Gupta, Allon N Friedman, Zeruesenay Desta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2022
A 58-Year-old Man With Multifocal Pulmonary NodulesMitchell McClean, Samir K Gupta, Ryan F Relich
European Journal of Clinical Pharmacology|December 17, 2010
Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis CSamir K Gupta, Karen Kolz, David L Cutler
AIDS Patient Care and Stds|April 8, 2011
Endothelial, inflammatory, coagulation, metabolic effects and safety of etravirine in HIV-uninfected volunteersSamir K Gupta, Deming Mi, Ziyue Liu, et al.
The Journal of Trauma|January 12, 2007
Splenic rupture after colonoscopy: case report and literature reviewSteven S Tsoraides, Samir K Gupta, Norman C Estes
AIDS (London, England)|May 12, 2016
Frequency of atazanavir-associated leukocyturia development and renal function declineLana Dbeibo, Sana Arif, Fei He, et al.
British Journal of Clinical Pharmacology|February 28, 2007
Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adultsSamir K Gupta, Bhavna Kantesaria, Christopher Banfield, et al.
British Journal of Clinical Pharmacology|July 10, 2003
Single-dose pharmacokinetics and tolerability of pegylated interferon-alpha2b in young and elderly healthy subjectsSamir K Gupta, Paul Glue, Sheila Jacobs, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2015
A randomized, controlled trial of the effect of rilpivirine versus efavirenz on cardiovascular risk in healthy volunteersSamir K Gupta, James E Slaven, Lisa M Kamendulis, et al.
Pageof 12